<http://www.wikidata.org/entity/statement/Q64805347-1FEE8283-E50D-4AF4-A479-8AC3BB4556E0>	<http://www.wikidata.org/prop/statement/P1476>	"A Phase 2, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of 3 Dose Levels of TAK-831 in Adjunctive Treatment of Adult Subjects With Negative Symptoms of Schizophrenia"@en .
<http://www.wikidata.org/entity/statement/Q64805347-1FEE8283-E50D-4AF4-A479-8AC3BB4556E0>	<http://wikiba.se/ontology#rank>	<http://wikiba.se/ontology#NormalRank> .
<http://www.wikidata.org/entity/statement/Q64805347-1FEE8283-E50D-4AF4-A479-8AC3BB4556E0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#BestRank> .
<http://www.wikidata.org/entity/statement/Q64805347-1FEE8283-E50D-4AF4-A479-8AC3BB4556E0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#Statement> .